Parasol Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$102K Sell
1,565
-1,470
-48% -$92.4K 0.17% 42
2016
Q4
$190K Sell
3,035
-50
-2% -$3.05K 0.2% 65
2016
Q3
$195K Sell
3,085
-460
-13% -$29.8K 0.2% 61
2016
Q2
$219K Sell
3,545
-520
-13% -$31.7K 0.23% 60
2016
Q1
$232K Buy
4,065
+150
+4% +$8.36K 0.23% 52
2015
Q4
$232K Sell
3,915
-1,778
-31% -$102K 0.22% 47
2015
Q3
$310K Sell
5,693
-2,361
-29% -$154K 0.28% 44
2015
Q2
$541K Sell
8,054
-350
-4% -$22.8K 0.36% 44
2015
Q1
$492K Buy
8,404
+6,925
+468% +$418K 0.31% 47
2014
Q4
$97K Hold
1,479
0.07% 84
2014
Q3
$85K Hold
1,479
0.06% 78
2014
Q2
$83K Hold
1,479
0.06% 80
2014
Q1
$76K Hold
1,479
0.05% 63
2013
Q4
$78K Buy
+1,479
New +$72.7K 0.05% 58

Other funds holding ABBV

Parasol Investment Management's ABBV Position: Q1 2017 in Review

Parasol Investment Management reduced its AbbVie (ABBV) stake by 48% in Q1 2017, selling an estimated $92.4K and leaving 1,565 shares worth $102K. The position accounts for 0.17% of the portfolio, ranked #42.

Parasol Investment Management first reported a position in ABBV in Q4 2013 and has held it in 14 quarters since. The position peaked at $541K in Q2 2015. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Parasol Investment Management held 1,565 shares of AbbVie worth $102K as of Q1 2017.
  • Parasol Investment Management sold 1,470 AbbVie shares in Q1 2017, an estimated $92.4K.
  • AbbVie made up 0.17% of Parasol Investment Management's portfolio in Q1 2017, its #42 holding.
  • Parasol Investment Management first reported a position in AbbVie in Q4 2013 and has held it in 14 quarters since.
  • Parasol Investment Management's AbbVie position peaked at $541K in Q2 2015.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Parasol Investment Management's 13F filing for Q1 2017, filed 24 Apr 2017.